Key points are not available for this paper at this time.
This study examines the impact of venture capital on corporate innovation performance and the moderating role of investor patience. We demonstrate that venture capital fosters exploitative innovation while hindering exploratory innovation. These effects are attributed to potential mechanisms such as sustained capital support, governance improvement and resource synergy. Additionally, we show that investor patience – reflected in investment modes like government involvement and syndication, as well as behavioral attributes such as long-term investment, post-investment stability, and failure tolerance – amplifies the positive effects of venture capital and mitigates its negative impact on exploratory innovation. Our findings provide novel insights into how patient capital contributes to innovation and how it can be institutionally cultivated.
Liang et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: